Anti-Xa Assay On-Board Stability Reduced from 7 to 5 Days
The HemosIL Liquid Anti-Xa diagnostic assay has reduced on-board stability from 7 days to 5 days. Laboratories should follow updated stability guidelines for all currently released and future lots.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (critical anticoagulation diagnostic) where reduced reagent stability could affect test accuracy. No illnesses or injuries have been reported to date, which caps the score at 3.
Plain-English summary
Instrumentation Laboratory is recalling the HemosIL Liquid Anti-Xa automated chromogenic assay due to a labeling correction for on-board instrument stability. The validated on-board stability period has been reduced from 7 days to 5 days for all currently released lots and future lots.
The HemosIL Liquid Anti-Xa assay is an in vitro diagnostic used by clinical laboratories to monitor anticoagulation therapy. The assay provides quantitative results on 3.2% citrated human plasma. Approximately 25,738 units have been distributed in the United States, with additional distribution to over 40 countries worldwide.
Laboratories using this assay should immediately review and implement the updated on-board stability specifications. The reagent should not be used beyond 5 days on the instrument. Labs should update their standard operating procedures and quality control measures to ensure compliance with the corrected stability guidelines.
The recalled product
- Product
- HemosIL Liquid Anti-Xa- automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay provides quantitative results on 3.2% citrated human plasma Part Number: 0020302602
- Manufacturer
- Instrumentation Laboratory
- Affected units
- 25,738
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All currently released lots and future lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Instrumentation Laboratory under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Instrumentation Laboratory
See all →- SevereGEM Premier 5000 PAK Lysing Solution Concentration Recall
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- HighPortable Blood Analyzer System Recalled Due to Barcode Reader Misidentification Risk
FDA (Devices) · 2026-08-05
- HighBar Code Reader Wands for GEM Premier Blood Analyzers Recalled Due to Misidentification Risk
FDA (Devices) · 2026-08-05
- HighBlood Analyzer Bar Code Reader May Assign Patient Results to Incorrect Patient ID
FDA (Devices) · 2026-08-05
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02